Insights On Regulatory Compliance
-
AI Agents: The Scientists' New Allies
3/24/2026
AI agents are reshaping biopharma research, offering new ways to analyze data. Find out how success depends on strong data foundations, governance, and thoughtful adoption strategies.
-
Nitrosamines - New Requirements To Evaluate Contamination Risks
12/23/2024
Explore nitrosamine contamination, regulatory actions, and new evaluation requirements, featuring expert insights from Dr. Ulrich Reichert on prevention and risk assessment strategies.
- ICH E6(R3) In Effect: Transforming Quality Management For Cell And Gene Therapy Trials 1/29/2026
-
How To Handle Intrinsic Product Powder Particles
3/16/2026
Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.
-
Robotics And AI In Pharma: Driving The Next Wave Of Innovation
2/23/2026
Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.
-
Practical Considerations For Aseptic Gowning In Contamination Control Strategies (CCS)
2/13/2026
Personnel remain the most significant contributor to contamination risk. Explore these practical considerations for your CCS to address complex interactions between operators and their environment
-
Top 3 Things To Consider When Designing A Risk-Based Cleaning Validation Process
10/23/2024
Learn how implementing a systematic approach to cleaning validation can significantly enhance compliance and improve your audit readiness.
-
Selecting A CDMO For Custom Activated PEGs
1/27/2026
Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
From Readiness To Results: Unlocking Capacity For Expanding Product Demand
11/18/2025
Learn the six pillars that bridge operational readiness and operational excellence. Discover a proven framework to build a resilient, high-performing manufacturing operation and unlock necessary capacity.
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
3/5/2025
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.